Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMWFM2T)

Drug Name	Edoxaban tosylate DMWFM2T
Synonyms	480449-71-6; Edoxaban (tosylate); Edoxaban TsOH; Edoxaban tosilate; UNII-32W99UE810; CHEBI:85975; 32W99UE810; SAVAYSA; Edoxaban tosylate [USAN]; Edoxaban TsOH salt; edoxaban monotosylate; edoxaban p-toluenesulfonate; edoxaban 4-toluenesulfonate; SCHEMBL330918; CHEMBL2105682; DTXSID10197399; ZLFZITWZOYXXAW-QXXZOGQOSA-N; BCP14472; C24H30ClN7O4S.C7H8O3S; 3601AH; HY-10264A; AKOS022186217; CS-1332; W-5624; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4-((dimethylamino)carbonyl)- 2-(((4,5,6,7
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Stroke	DISX6UHX	8B20	Approved	[1]
Venous thromboembolism	DISUR7CR	BD72	Approved	[1]
Embolism	DISOGP81	JB42	Approved	[1]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of Daiichi Sankyo.